Pradaxa (Dabigatran Etexilate) VTE Prevention After Elective Total Hip or Knee Replacement Surgery

NCT01153698 · clinicaltrials.gov ↗

TERMINATED

Status

167

Enrollment

INDUSTRY

Sponsor class

Stopped This trial was prematurely discontinued due to low enrolment.

Conditions

Venous Thromboembolism
Arthroplasty, Replacement

Interventions

DRUG: dabigatran

Sponsor

Boehringer Ingelheim